Latvia vs Vietnam: Cause of death, by non-communicable diseases, ages 15-59, male
Latvia
68.8%
in 2021
Vietnam
68.3%
in 2021
Latvia rank
35th
Vietnam rank
36th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Latvia
- Vietnam
How they compare
Latvia currently reports 68.8% against 68.3% in Vietnam, a difference of 0.5%.
Across all 6 years both countries report, Latvia has been ahead every year.
Latvia ranks 35th and Vietnam ranks 36th of 185 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 58.5% | 49.7% | 8.7% | Latvia |
| 2010s | 70.1% | 65.2% | 4.9% | Latvia |
| 2020s | 70.3% | 69.2% | 1.1% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Latvia or Vietnam?
- Latvia, at 68.8% against 68.3% in Vietnam as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Latvia and Vietnam?
- 0.5%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Vietnam?
- 6 years are reported by both, from 2000 to 2021.
- How do Latvia and Vietnam rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Latvia ranks 35th and Vietnam ranks 36th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.